Lestaurtinib CAS: 111358-88-4
| Product Parameters | |
|---|---|
| Catalog No. | BA757C |
| CAS.RN | 111358-88-4 |
| Molecular Formula | C26H21N3O4 |
| Molecular Weight | 439.469 g/mol |
| Purity | NLT 98% |
Product Overview
Lestaurtinib is a highly selective multi-target tyrosine kinase inhibitor widely used in the research and development and production of anti-tumor drugs, particularly for the treatment of hematologic malignancies such as leukemia and lymphoma. This product can meet the full lifecycle needs from laboratory research and development, small-scale preparation to pilot-scale amplification and commercial production. It is suitable for pharmaceutical intermediate synthesis, process optimization, and customized supply scenarios, and is an important raw material for pharmaceutical companies in new drug development and process improvement.
Applications
- Anti-tumor drug development
- Leukemia treatment drug synthesis
- Tyrosine kinase inhibitor process optimization
- Custom synthesis of pharmaceutical intermediates
- Preclinical research and formulation development
Quality & Supply Capability
English Name: Lestaurtinib Properties: White to off-white crystalline powder with good thermal and chemical stability. Contains a quinazoline ring structure, exhibiting potent kinase inhibitory activity. Storage Recommendations: Store in a sealed, light-protected, and dry place, referring to the COA/MSDS for specific requirements. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from sample supply, small-scale preparation, pilot-scale amplification to customized batch production. We can flexibly adjust supply solutions according to customer requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documentation. We also have a professional technical support team to assist customers in completing process development, route optimization, and project transformation from laboratory R&D to industrial production, ensuring an efficient, compliant, and stable supply chain.
Why Choose Bioncan
Focused on supplying pharmaceutical intermediates and APIs, with extensive industry experience. Full-scale supply capabilities, covering needs from laboratory to commercial production. Provides complete quality control documentation, complying with international pharmaceutical regulatory standards. Supports customized needs, adjusting purity, impurity control, and packaging specifications as required. Supports process optimization and technical support to facilitate successful project scaling and commercialization.
Intermediates of Lestaurtinib
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA757C | Lestaurtinib API | 111358-88-4 |
| BK08P6 | Methyl 1-((3-fluoro-4-(methylcarbamoyl)phenyl)amino) cyclobutanecarboxylate | 2227589-23-1 |
| BK6FP9 | 1-((3-fluoro-4-(methylcarbamoyl)phenyl)amino)cyclobutanecarboxylic acid | 2227589-22-0 |
| BK2FN6 | 1-Amino-1-cyclobutanecarboxylic acid hydrochloride | 98071-16-0 |
| BK0T66 | 4-Bromo-2-fluoro-N-methylbenzamide | 749927-69-3 |
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 111358-88-4, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.